MA-CRC-II-016 SHR-1811

Clinical trial NCT07355764 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07355764
Sponsor: Peking Union Medical College Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

mCRC HER2 Targeted Therapy Antibody-drug Conjugates

Start date: 2025-12-30
Primary completion: 2028-01-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.